HER2-targeted monoclonal antibody therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HER2-targeted monoclonal antibody therapy, covering 2025-11-06 to 2025-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer [Phase 2]